Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimportation Vote Planned In House; Advocates Say Must Be In Medicare

Executive Summary

The House leadership is planning an "up-or-down" vote on reimportation legislation that may determine the fate of efforts to open the U.S. border to Canadian drugs

You may also be interested in...



GAO Internet Rx Study Should Include Role Of Credit Cards – Rep. Dingell

The sale of prescription drugs over the Internet could be prevented if credit card companies monitored the websites that use their services, House Energy & Commerce Committee Ranking Member John Dingell (D-Mich.) suggests in a Nov. 13 letter to GAO

GAO Internet Rx Study Should Include Role Of Credit Cards – Rep. Dingell

The sale of prescription drugs over the Internet could be prevented if credit card companies monitored the websites that use their services, House Energy & Commerce Committee Ranking Member John Dingell (D-Mich.) suggests in a Nov. 13 letter to GAO

Burton Medicare “Fallback” Plan Would Allow HHS To Negotiate Rx Prices

House Government Reform/Human Rights & Wellness Subcommittee Chairman Dan Burton's (R-Ind.) proposed alternative to passing a full Medicare prescription drug benefit would rely on the government's ability to negotiate prices to maintain affordability of the program

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042067

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel